Cej. Vanrensburg et al., EVALUATION OF THE ANTINEOPLASTIC ACTIVITIES OF THE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 IN TUMOR-BEARING RATS AND MICE, International journal of oncology, 3(5), 1993, pp. 1011-1013
The riminophenazine agents clofazimine and its analogue B669 displayed
anti-tumor activity at 30 mg/kg/day in benzo[a]pyrene (BP) induced sa
rcomas of mice as well as dimethylbenz-anthracene (DMBA)-induced rat m
ammary tumors. No hematological toxicity of these drugs at doses up to
60 mg/kg/day for one month was observed. This is the first study to d
ocument in vivo anti-neoplastic activities of clofazimine and B669.